IPP Bureau
Patritumab Deruxtecan shows better clinical activity in patient with lung and breast cancer
By IPP Bureau - March 20, 2023
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data
By IPP Bureau - March 20, 2023
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
By IPP Bureau - March 20, 2023
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit
By IPP Bureau - March 19, 2023
The observations are procedural in nature
Nutricircle introduces nutrition based plant Protein isolates
By IPP Bureau - March 18, 2023
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex
By IPP Bureau - March 18, 2023
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Lupin Digital Health reveals results of digital therapeutics study with ACS patients
By IPP Bureau - March 18, 2023
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO
By IPP Bureau - March 18, 2023
He is Proficient in overseeing and leading teams for running successful business operations
Drug coated balloons is an alternative to stents in younger patients: Experts
By IPP Bureau - March 18, 2023
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals
By IPP Bureau - March 18, 2023
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
By IPP Bureau - March 17, 2023
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
By IPP Bureau - March 17, 2023
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences
By IPP Bureau - March 17, 2023
Mindset disagrees with and denies the allegations set forth from Reunion.
ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
By IPP Bureau - March 17, 2023
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth
By IPP Bureau - March 17, 2023
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
